| Financial Year |
March 31 2023 |
| Monetary Funds |
122,071,974.87 |
| Held-for-trading Financial Assets |
119,000,000.00 |
| Notes Receivable |
100,000,000.00 |
| Accounts Receivable |
625,897,188.34 |
| Advances to Suppliers |
52,000,987.05 |
| Other Receivables |
354,378,130.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
66,874,445.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
421,102,618.97 |
| Other Current Assets |
508,501,911.95 |
| Total Current Assets |
3,396,808,261.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,803,422,125.87 |
| Long-term Equity Investment |
2,917,306.26 |
| Investment Properties |
1,078,863.87 |
| Fixed Assetes |
41,689,383.02 |
| Under-construction Projects |
24,569,882.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,189,304.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,361,348.17 |
| Deferred Income Tax Assets |
121,475,073.80 |
| Other Non-Current Assets |
925,974,083.83 |
| Sub-Total of Non-Current Assets |
3,984,969,927.97 |
| Total Assets |
7,381,778,189.64 |
| Short-Term Loans |
10,016,666.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,420,481,194.70 |
| Accounts Received In Advance |
1,585,941.70 |
| Employee Compensation Payable |
12,766,637.72 |
| Taxes Payable |
15,259,585.17 |
| Interest Payable |
-- |
| Dividend Payable |
52,726.57 |
| Other payables |
578,938,640.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
108,975,081.17 |
| Other Current Liabilities |
292,412,629.14 |
| Sub-Total of Current Liabilities |
2,501,304,682.59 |
| Long-term Loans |
1,501,423,553.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
31,287,908.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,847,604.93 |
| Deferred Income Tax Liabilities |
86,342,856.87 |
| Other Non-Current Liabilities |
171,650,000.00 |
| Sub-Total of Non-Current Liabilities |
1,799,184,674.16 |
| Total Liabilities |
4,300,489,356.75 |
| Paid-In Capital(Or Share Stock) |
757,194,315.00 |
| Capital Surplus |
905,845,826.01 |
| Surplus Reserve |
145,583,243.31 |
| LESS:Treasury Stock |
209,397.00 |
| Undistributed Profits |
1,162,625,568.94 |
| Minority Stockholder's Interest |
76,970,128.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,004,318,703.95 |
| Owner's Equity（Stockholder's Equity） |
3,081,288,832.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,381,778,189.64 |
